Home VCU receives $1.9 million grant to research chemical compounds for treating addiction
News and Views

VCU receives $1.9 million grant to research chemical compounds for treating addiction

AFP

vcu-logoDrug development research by Virginia Commonwealth University School of Pharmacy associate professor Yan Zhang, Ph.D., at the Schools of Pharmacy and Medicine has been renewed by the National Institutes of Health for the next five years with funding of $1.9 million. The threefold study is geared toward developing new chemical entities to treat substance abuse disorders.

“A lot of treatments for drug abuse and addiction, particularly for opioids, have all the side effects that the drugs themselves have,” said Zhang, who is the principal investigator for the multidisciplinary research project that began in his lab at the Department of Medicinal Chemistry in 2005. “We are looking for better treatments,” he said.

Zhang’s lab targets mu-opioid receptors, which are one of three opioid receptors that trigger the brain’s rewards system and are thought to contribute to addictive behaviors. “By not blocking the function of the other two receptors, you will avoid a lot of side effects that could be generated if the chemical was not selective to mu-receptors,” Zhang said.

The first aim of the research is to develop a drug that will lessen the effects of addiction to opioids such as morphine. The second research purpose is to lessen the effects of addiction to stimulants such as cocaine. Thirdly, the lab is working on a compound that will treat constipation related to opioid use.

“Later-stage cancer patients are going to have to take opioids to treat pain,” Zhang said, adding that up to 75 percent of patients who take opioids will develop constipation. “The third purpose of our research is to benefit this group of patients.”

Research through Zhang’s lab has already resulted in more than two dozen published articles in peer-reviewed academic journals and two pending patents for various chemical compounds, as well as one licensed patent. With this second phase of funding, the research team will continue to identify structurally diverse chemical entities intended to target the mu-opioid receptor, and they hope to develop a medication that will address the three research focus areas.

 

Support AFP

Newsletter

Featured Video

 

 




AFP

AFP

Have a guest column, letter to the editor, story idea or a news tip? Email editor Chris Graham at [email protected]. Subscribe to AFP podcasts on Apple Podcasts, Spotify, Pandora and YouTube. Support AFP by signing up for our newsletter and/or powering our work with a one-time or monthly contribution.

Latest News

newspaper online news AFP mobile phone newsfeed
Local

AFP needs to do more: Just warning you, we’re going to ask for your help to get there

uva central grounds
Football, Go 'Hoos

Conservative alums lead the fight to hold UVA accountable for the failures of Nov. 13

The University of Virginia wants us to believe that because it rings church bells every Nov. 13, the anniversary of the mass shooting that killed three UVA Football players, that it’s doing all it can do to honor the memories of Lavel Davis Jr., Devin Chandler and D’Sean Perry.

mobile games casino phone computer
Politics, Virginia

State AGs pushing Trump FCC to take real steps to get rid of annoying robocalls

I get so many robocalls that I’ve been at least half-seriously considering opting out of having a phone number going forward, and if I’ve given you an idea here, feel free to run with it.

uva basketball thijs de ridder
Basketball, Go 'Hoos

UVA Basketball: NBA-like early schedule, tempo, defense, Gertrude/de Ridder

pit bull dog
Football, Go 'Hoos

UVA Football: Elliott, prodded by the media, heaps the praise on Solomon Beebe

uva basketball swish
Basketball, Go 'Hoos

UVA Basketball: #4 ‘Hoos defeat gritty ODU, 85-65, to win battle of unbeatens

ben cline
Politics, Virginia

Ben Cline announces series of town halls, with a catch, in the form of a waitlist